{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:02:09Z","timestamp":1792598529997,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017501","name":"Science Health Joint Medical Scientific Research Project of Chongqing","doi-asserted-by":"publisher","award":["2020ZY023716"],"award-info":[{"award-number":["2020ZY023716"]}],"id":[{"id":"10.13039\/100017501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.phymed.2025.156871","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T15:33:01Z","timestamp":1748878381000},"page":"156871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Effects of Chinese herbal medicine on the secondary prevention of chemotherapy-induced thrombocytopenia in malignant solid tumors, a randomized clinical trial"],"prefix":"10.1016","volume":"144","author":[{"given":"Yanan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Duo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunjie","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.phymed.2025.156871_bib0001","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1182\/blood.V99.7.2599","article-title":"Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor","volume":"99","author":"Basser","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.phymed.2025.156871_bib0002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/10428190600909115","article-title":"The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes","volume":"48","author":"Bhatia","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.phymed.2025.156871_bib0003","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jep.2018.11.018","article-title":"Danggui Buxue Tang promotes the adhesion and migration of bone marrow stromal cells via the focal adhesion pathway in vitro","volume":"231","author":"Bo","year":"2019","journal-title":"J. Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.phymed.2025.156871_bib0004","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2141.2004.05281.x","article-title":"Phase I\/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study","volume":"128","author":"Cairo","year":"2005","journal-title":"Br. J. Haematol"},{"issue":"12","key":"10.1016\/j.phymed.2025.156871_bib0005","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1002\/cncr.11447","article-title":"Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy","volume":"97","author":"Cantor","year":"2003","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.phymed.2025.156871_bib0006","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3324\/haematol.2018.212845","article-title":"Thrombopoietin receptor agonists: ten years later","volume":"104","author":"Ghanima","year":"2019","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.phymed.2025.156871_bib0007","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1002\/ptr.7782","article-title":"Danggui Buxue Tang potentiates the cytotoxicity of 5-fluorouracil on colorectal adenocarcinoma cells: A signaling mediated by c-Jun N-terminal kinase","volume":"37","author":"Gong","year":"2023","journal-title":"Phytother. Res"},{"issue":"3","key":"10.1016\/j.phymed.2025.156871_bib0008","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/1534735416675952","article-title":"Danggui Buxue Decoction, a classical formula of traditional Chinese Medicine, fails to prevent myelosuppression in breast cancer patients treated with adjuvant chemotherapy: A prospective study","volume":"16","author":"Hong","year":"2017","journal-title":"Integr. Cancer Ther"},{"issue":"2","key":"10.1016\/j.phymed.2025.156871_bib0009","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/bjh.12772","article-title":"Thrombopoietin from beginning to end","volume":"165","author":"Hitchcock","year":"2014","journal-title":"Br. J. Haematol"},{"issue":"6","key":"10.1016\/j.phymed.2025.156871_bib0010","first-page":"1679","article-title":"The antiapoptotic effect of Danggui Buxue Tang and its main components on hematopoietic cells in mice with bone marrow suppression","volume":"30","author":"Kong","year":"2022","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"11","key":"10.1016\/j.phymed.2025.156871_bib0011","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1182\/blood-2006-10-019315","article-title":"New thrombopoietic growth factors","volume":"109","author":"Kuter","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.phymed.2025.156871_bib0012","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3324\/haematol.2021.279512","article-title":"Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies","volume":"107","author":"Kuter","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.phymed.2025.156871_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.113965","article-title":"Danggui Buxue Decoction enhances the anticancer activity of gemcitabine and alleviates gemcitabine-induced myelosuppression","volume":"273","author":"Liu","year":"2021","journal-title":"J. Ethnopharmacol"},{"issue":"16","key":"10.1016\/j.phymed.2025.156871_bib0014","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s40265-021-01613-y","article-title":"Avatrombopag: A review in thrombocytopenia","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.phymed.2025.156871_bib0015","doi-asserted-by":"crossref","first-page":"e5379","DOI":"10.1002\/bmc.5379","article-title":"Metabolomics study of the effect of Danggui Buxue Tang on rats with chronic fatigue syndrome","volume":"36","author":"Miao","year":"2022","journal-title":"Biomed. Chromatogr"},{"issue":"6","key":"10.1016\/j.phymed.2025.156871_bib0016","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1089\/acm.2018.0470","article-title":"Chinese Herbal Medicine (Xiaoaiping) Injections for Chemotherapy-Induced Thrombocytopenia: A Randomized, Controlled, Multicenter Clinical Trial","volume":"25","author":"Qi","year":"2019","journal-title":"J. Altern. Complement. Med"},{"issue":"31","key":"10.1016\/j.phymed.2025.156871_bib0017","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1200\/JCO.18.01931","article-title":"Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia","volume":"37","author":"Soff","year":"2019","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.phymed.2025.156871_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114699","article-title":"Integrated lipidomics, transcriptomics and network pharmacology analysis to reveal the mechanisms of Danggui Buxue Decoction in the treatment of diabetic nephropathy in type 2 diabetes mellitus","volume":"283","author":"Sun","year":"2022","journal-title":"J. Ethnopharmacol"},{"issue":"8","key":"10.1016\/j.phymed.2025.156871_bib0019","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00520-011-1290-x","article-title":"Multicenter, randomized study of genetically modified recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in cancer patients receiving chemotherapy","volume":"20","author":"Wu","year":"2012","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.phymed.2025.156871_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4201325","article-title":"Use of Chinese Herbal Medicine Improves Chemotherapy-Induced Thrombocytopenia among Gynecological Cancer Patients: An Observational Study","volume":"2018","author":"Wu","year":"2018","journal-title":"Evid. Based Complement. Altern. Med"},{"issue":"2","key":"10.1016\/j.phymed.2025.156871_bib0021","first-page":"485","article-title":"A Clinical Study on Juheli (Recombinant Human Interleukin - 11) in the Second Prevention of Chemotherapy Induced Thrombocytopenia. Asian Pac","volume":"17","author":"Xiao","year":"2016","journal-title":"J. Cancer Prev"},{"key":"10.1016\/j.phymed.2025.156871_bib0022","doi-asserted-by":"crossref","DOI":"10.1177\/1534735419829568","article-title":"Effects of Shen Cao Granules on Chemotherapy-Induced Thrombocytopenia in Gastrointestinal Cancer Patients: A Randomized Controlled Trial","volume":"18","author":"Yu","year":"2019","journal-title":"Integr. Cancer Ther"},{"issue":"11","key":"10.1016\/j.phymed.2025.156871_bib0023","article-title":"Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours","volume":"11","author":"Zhang","year":"2017","journal-title":"Cochrane Database Syst. Rev"},{"issue":"8","key":"10.1016\/j.phymed.2025.156871_bib0024","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.21037\/apm-22-880","article-title":"Cost-effectiveness analysis of rhTPO and rhIL-11 in the treatment of chemotherapy-induced thrombocytopenia in hematological tumors based on real-world data","volume":"11","author":"Zhang","year":"2022","journal-title":"Ann. Palliat. Med"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325005094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325005094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T21:57:46Z","timestamp":1750283866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325005094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":24,"alternative-id":["S0944711325005094"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156871","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Chinese herbal medicine on the secondary prevention of chemotherapy-induced thrombocytopenia in malignant solid tumors, a randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"156871"}}